Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/24211| Title: | Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis (PSA) through 3 years: efficacy and safety results from a phase 3 trial | Authors: | Hall, S. Mease, P. Kavanaugh, A. Reimold, A. Tahir, H. Rech, J. GEUSENS, Piet Pascale, P. Delicha, E. Pricop, L. Mpofu, S. |
Issue Date: | 2017 | Publisher: | WILEY | Source: | INTERNAL MEDICINE JOURNAL, 47, p. 37-38 (Art N° P90) | Abstract: | Secukinumab, an anti–interleukin-17A monoclonal antibody, provided rapid and significant improvements in the key clinical domains of psoriatic arthritis (PsA) in the FUTURE 1 study (NCT01392326) with improvements sustained through 2 years. Here, we present efficacy and safety results through 3 years in the extension of the FUTURE 1 study. | Notes: | [Hall, S.] Monash Univ, Melbourne, Vic, Australia. [Mease, P.] Swedish Med Ctr, Seattle, WA USA. [Mease, P.] Univ Washington, Seattle, WA 98195 USA. [Kavanaugh, A.] Univ Calif San Diego, Sch Med, La Jolla, CA USA. [Reimold, A.] Dallas VA Med Ctr, Dallas, TX USA. [Reimold, A.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA. [Tahir, H.] Barts Hlth NHS Trust, London, England. [Rech, J.] Friedrich Alexander Univ Erlangen Narnberg Fau, Univ Klinikum Erlangen, Dept Internal Med Rheumatol & Immunol, Erlangen, Germany. [Geusens, P.] Univ Hasselt, Hasselt, Belgium. [Geusens, P.] Maastricht Univ Hosp, Maastricht, Netherlands. [Pascale, P.; Delicha, E.; Mpofu, S.] Novartis Pharma Ag, Basel, Switzerland. [Pricop, L.] Novartis Pharmaceut, E Hanover, NJ USA. | Document URI: | http://hdl.handle.net/1942/24211 | Link to publication/dataset: | http://acrabstracts.org/abstract/secukinumab-provides-sustained-improvements-in-the-signs-and-symptoms-of-active-psoriatic-arthritis-through-3-years-efficacy-and-safety-results-from-a-phase-3-trial/ | ISSN: | 1444-0903 | e-ISSN: | 1445-5994 | ISI #: | 000400304400113 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| acrabstracts_org_abstract_secukinumab_provides_sustained_imp.pdf | Published version | 65.7 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.